In previous studies, mTOR signaling was identified as a critical regulatory pathway in these neurodegenerative disorders [38], and inactivation of mTOR by rapamycin has been regarded to be a potential therapeutic method in the treatment of Alzheimer’s disease [39]. The gene discussed is MTOR; the disease is early-onset autosomal dominant Alzheimer disease.